Navigating Long-Term Responses in Breast Cancer Treatment

This chapter examines the intricate dynamics of treating hormone receptor-positive, HER2-negative metastatic breast cancer patients who display remarkable treatment responses. It also discusses the challenges of delayed recurrences and the role of the immune system in patient outcomes, emphasizing the potential for improved prognoses in late relapses.